Gastrointestinal Cancer Devices

Gastrointestinal Cancer Devices Market Outlook

The global gastrointestinal cancer devices market is anticipated to reach a valuation of approximately USD 10 billion by 2035, growing at a notable CAGR of around 7.5% during the forecasting period of 2025 to 2035. The growth of this market can be largely attributed to the increasing prevalence of gastrointestinal cancers worldwide, which necessitates advanced diagnostic and therapeutic interventions. With the rise in geriatric populations, alongside lifestyle factors such as poor diet and sedentary behavior, the incidence of gastrointestinal cancers is on the rise. Furthermore, technological advancements in medical devices are enhancing the efficacy of cancer diagnostics and treatment, thereby propelling market growth. The growing focus on minimally invasive surgical procedures also contributes to the demand for innovative gastrointestinal devices.

Growth Factor of the Market

The gastrointestinal cancer devices market is fueled by several pivotal growth factors that are transforming the landscape of cancer care. One of the most significant drivers is the increasing awareness about early diagnosis and treatment of gastrointestinal cancers, which prompts the demand for advanced devices that allow for effective monitoring and intervention. Additionally, the rise in government and private investments aimed at cancer research and development is enhancing the production and availability of cutting-edge medical technologies. Innovations in endoscopic and surgical devices, alongside improvements in imaging technologies, are helping healthcare professionals offer better diagnostic and therapeutic solutions for patients. Moreover, the trend towards outpatient procedures has increased the demand for specialized ambulatory surgical centers, where sophisticated gastrointestinal devices are critical. Lastly, the growing prevalence of chronic conditions and comorbidities associated with gastrointestinal cancers necessitates the availability of supportive care devices, further driving market growth.

Key Highlights of the Market

• Significant growth projected in the gastrointestinal cancer devices market with a CAGR of 7.5%.
• Technological advancements improving diagnostic accuracy and treatment outcomes.
• Rising investment in cancer research and healthcare infrastructure.
• Increased demand for minimally invasive surgical procedures driving device adoption.
• Growing prevalence of gastrointestinal cancers worldwide motivating market expansion.

By Product Type

Endoscopic Devices:

Endoscopic devices represent a crucial segment within the gastrointestinal cancer devices market, primarily utilized for both diagnostic and therapeutic purposes. These devices enable healthcare professionals to visualize the gastrointestinal tract, thereby allowing for the early detection of cancers and related abnormalities. The advancements in endoscopic technology, such as high-definition imaging and minimally invasive techniques, have significantly increased their adoption in clinical practices. With the growing number of outpatient procedures, endoscopic devices are becoming increasingly popular due to their ability to offer rapid recovery times and reduce hospital stays. Moreover, companies are continuously innovating to enhance endoscopic functionalities, such as incorporating artificial intelligence for better diagnosis and treatment planning, further fueling market growth.

Surgical Devices:

Surgical devices form another vital component of the gastrointestinal cancer devices market, playing a significant role in the surgical management of cancerous conditions. These devices encompass a wide array of instruments, including surgical robots, laparoscopic tools, and various types of surgical sutures. The trend towards minimally invasive surgeries has led to the increased usage of laparoscopic devices that reduce patient recovery time and minimize surgical risks. Furthermore, the integration of robotic surgical systems is revolutionizing the landscape, providing surgeons with enhanced precision and control during complex procedures. As more healthcare facilities adopt these advanced surgical devices, the overall effectiveness of gastrointestinal cancer surgeries is improving, contributing to better patient outcomes and driving the market forward.

Diagnostic Devices:

Diagnostic devices are essential in the early detection of gastrointestinal cancers, thereby playing a critical role in improving patient prognosis. These devices include imaging technologies such as MRI, CT scans, and biopsy tools, which facilitate thorough examinations of the gastrointestinal tract. The increasing emphasis on early diagnosis, combined with technological advancements that enhance imaging clarity and resolution, is driving the demand for these devices. Additionally, the incorporation of molecular diagnostics and biomarkers in the diagnostic process is further elevating the capabilities of traditional diagnostic devices. As healthcare professionals strive for early intervention strategies, the role of diagnostic devices in the management of gastrointestinal cancers is becoming increasingly pivotal, thus stimulating the market's growth.

Therapeutic Devices:

Therapeutic devices in the gastrointestinal cancer devices market are primarily designed to provide treatment options for patients diagnosed with cancer. This category includes chemotherapy delivery systems, radiation therapy devices, and devices used for ablation and targeted therapies. With the continuous development of novel therapeutic strategies, the effectiveness of these devices is significantly enhanced, leading to improved patient outcomes. The rising incidence of gastrointestinal cancers necessitates a diverse range of therapeutic options, driving the demand for innovative devices that cater to various treatment modalities. The ongoing research into personalized medicine further contributes to the growth of therapeutic devices, as tailored treatments become more prevalent in cancer care, underlining the importance of this segment in the market.

Supportive Care Devices:

Supportive care devices are designed to aid in the management of symptoms and improve the quality of life for patients undergoing treatment for gastrointestinal cancers. This segment includes devices for pain management, nutritional support, and palliative care. The increasing recognition of the importance of supportive care in oncology is fueling the demand for these devices, as healthcare providers strive to address not only the disease but also the overall well-being of patients. As the focus shifts toward holistic approaches in cancer treatment, supportive care devices are becoming integral to oncology care settings. Furthermore, advancements in technology are enabling the development of innovative supportive care solutions that cater to the specific needs of gastrointestinal cancer patients, thus enhancing their comfort and quality of life.

By Application

Hospitals:

Hospitals are a primary application segment for gastrointestinal cancer devices, serving as critical hubs for diagnosis, treatment, and ongoing patient management. These institutions are equipped with advanced technologies and specialized medical teams that handle complex cancer cases. The comprehensive range of services offered at hospitals, including surgical procedures, chemotherapy, and radiation therapy, necessitates the availability of various gastrointestinal cancer devices. With an increasing number of patients being diagnosed with gastrointestinal cancers, hospitals are continuously investing in the latest medical technologies to ensure optimal care delivery. The focus on improving patient outcomes and maintaining high standards of care further reinforces the significance of hospitals as a key application segment in the market.

Clinics:

Clinics, particularly specialty clinics focused on oncology, are becoming increasingly important in the gastrointestinal cancer devices market. These facilities often provide targeted services for early diagnosis and treatment of gastrointestinal cancers in a more personalized setting. The growing trend towards outpatient care is driving the demand for advanced diagnostic and therapeutic devices within clinics, allowing for more efficient patient management. Moreover, clinics are often more accessible to patients, enabling quicker consultations and interventions that can lead to early detection and better treatment outcomes. As healthcare continues to evolve, clinics are positioning themselves as valuable players in the gastrointestinal cancer care continuum, contributing to market growth.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are rapidly gaining prominence in the gastrointestinal cancer devices market, primarily due to their focus on outpatient procedures. These centers offer a range of minimally invasive surgical options that allow patients to undergo procedures without the need for overnight hospitalization. The demand for ASCs is increasing, driven by patient preferences for convenience and cost-effectiveness. Furthermore, the advancements in surgical devices and techniques that facilitate outpatient procedures contribute to the growth of this segment. ASCs are also becoming vital for follow-up care and monitoring post-procedure, reinforcing their role in the gastrointestinal cancer care ecosystem and driving demand for specialized devices.

Cancer Research Institutes:

Cancer research institutes play a crucial role in the advancement of gastrointestinal cancer devices through research and development efforts. These institutions are at the forefront of innovation, working to develop new diagnostic and therapeutic technologies that can significantly improve patient outcomes. Collaborations between research institutes and medical device manufacturers often lead to breakthroughs in gastrointestinal cancer care, including the development of novel imaging techniques or therapeutic devices tailored for specific cancer types. As research institutes continue to explore new frontiers in cancer treatment, their influence on the gastrointestinal cancer devices market is substantial, driving demand for innovative solutions that can be translated into clinical practice.

Others:

In addition to hospitals, clinics, ambulatory surgical centers, and cancer research institutes, there are other applications of gastrointestinal cancer devices that contribute to market growth. These include private practices, community health organizations, and telemedicine platforms that are increasingly being utilized for cancer care. The rising adoption of telehealth services has further expanded the reach of gastrointestinal cancer devices, making them accessible to a broader patient population. As healthcare delivery models evolve, these alternative applications are gaining traction, thus adding diversity to the overall market landscape for gastrointestinal cancer devices. The adaptability of these devices across various settings supports the growth potential of the market as a whole.

By User

Hospitals:

Hospitals remain the predominant users of gastrointestinal cancer devices due to their comprehensive services and expertise in managing complex cancer cases. These institutions often have dedicated oncology departments equipped with the latest technology and skilled professionals who can provide diagnostic, surgical, and therapeutic interventions. The high patient volume in hospitals necessitates a constant supply of advanced devices, ranging from endoscopic tools to surgical instruments. Hospitals also play a significant role in clinical trials and research, contributing to the advancement of new technologies. As the demand for gastrointestinal cancer treatment continues to rise, hospitals will likely continue to be the primary users of these devices, ensuring that they stay at the forefront of cancer care.

Specialty Clinics:

Specialty clinics focused on oncology are increasingly becoming significant users of gastrointestinal cancer devices, particularly for outpatient services. These clinics provide targeted care for patients diagnosed with gastrointestinal cancers, often offering advanced diagnostic tools and therapeutic options. The focus on personalized care allows specialty clinics to tailor their services to the specific needs of patients, enhancing the effectiveness of treatments. Additionally, the rise in patient awareness and preference for specialized care is driving more individuals to seek treatment at these clinics, leading to an increased demand for gastrointestinal devices. As the market evolves, specialty clinics are likely to play an even larger role in the utilization of these devices, emphasizing the need for innovation and adaptability in the sector.

Cancer Research Institutes:

Cancer research institutes are vital users of gastrointestinal cancer devices, primarily for the purposes of research and clinical trials. These institutions utilize advanced devices to study gastrointestinal cancers, aiming to develop new diagnostic techniques and treatment modalities. The integration of cutting-edge technologies allows researchers to explore novel approaches to cancer care, thereby contributing to the overall advancement of the field. Partnerships between research institutes and medical device manufacturers often lead to the rapid development and testing of innovative solutions, which can subsequently be brought to market. As research efforts continue to expand, the role of cancer research institutes as users of gastrointestinal cancer devices will become increasingly important.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are also significant users of gastrointestinal cancer devices, particularly for performing outpatient surgical procedures. These centers are designed to provide a range of surgical services without the need for hospital stays, catering to the growing demand for minimally invasive interventions. ASCs are equipped with specialized devices that enable them to offer high-quality care in a cost-effective manner. The increasing trend towards outpatient surgeries is driving more patients to seek treatment in ASCs, leading to a corresponding rise in the utilization of gastrointestinal cancer devices. As this trend continues, ASCs are expected to become increasingly important users of these devices in the cancer care landscape.

By Region

The gastrointestinal cancer devices market is experiencing varied growth trajectories across different regions, with North America leading the charge due to its advanced healthcare infrastructure and high investment in medical technology. The region is projected to account for over 40% of the global market share by 2035, driven by a robust demand for innovative diagnostic and therapeutic devices that cater to the rising incidence of gastrointestinal cancers. The United States, in particular, is home to numerous leading medical device manufacturers, enhancing the availability and adoption of sophisticated devices. With a CAGR of approximately 8% expected in North America, the market is poised for substantial growth as healthcare providers continue to prioritize advanced cancer care solutions.

Europe follows closely as a significant market for gastrointestinal cancer devices, with a projected market share of around 30% by 2035. The region's emphasis on early detection and treatment of cancers, bolstered by government initiatives to improve healthcare access, drives the demand for advanced medical devices. Countries such as Germany, France, and the UK are at the forefront of this growth, investing heavily in research and development to enhance cancer care technologies. Additionally, the Asia Pacific region is anticipated to witness the highest growth rate, with a CAGR of 9% during the forecast period, attributed to the increasing prevalence of gastrointestinal cancers and rising healthcare expenditure. The growing number of cancer research initiatives and collaborations in countries like India and China further supports the expansion of the market in this region.

Opportunities

The gastrointestinal cancer devices market presents numerous opportunities that can be leveraged for substantial growth. One of the most significant opportunities lies in the expansion of personalized medicine, which is increasingly being adopted in cancer care. This approach tailors treatment strategies to individual patient profiles, allowing for more effective and targeted therapies. As the demand for personalized treatments rises, manufacturers of gastrointestinal cancer devices can innovate to develop specialized instruments that cater to these personalized approaches. Furthermore, the increasing use of telehealth and remote monitoring technologies opens new avenues for device manufacturers to integrate their products with digital health solutions, improving accessibility and patient management. By capitalizing on these trends, companies can position themselves favorably in the evolving market landscape.

Another noteworthy opportunity arises from the growing emphasis on preventive healthcare and early detection of gastrointestinal cancers. Awareness campaigns and educational initiatives aimed at the general population are contributing to a shift in focus towards screening and early diagnosis. This trend is creating a demand for advanced diagnostic devices that can identify cancers at their nascent stages, significantly improving patient outcomes. Moreover, strategic collaborations between medical device manufacturers, healthcare providers, and research institutes can lead to the development of innovative solutions that meet the increasing demands for effective gastrointestinal cancer care. By actively engaging in partnerships, companies can drive research and development efforts that yield cutting-edge devices, further enhancing their market presence.

Threats

The gastrointestinal cancer devices market faces several threats that could potentially hinder its growth trajectory. One of the primary concerns is the stringent regulatory environment that governs the approval and commercialization of medical devices. The lengthy and complex regulatory processes can delay the entry of innovative products into the market, posing challenges for manufacturers seeking to compete effectively. Additionally, the prevalence of counterfeit medical devices poses a significant threat to both patient safety and brand integrity. As counterfeit products become more sophisticated, they could undermine the trust of patients and healthcare professionals in legitimate devices, ultimately impacting market growth. Companies must remain vigilant and proactive in addressing these challenges to maintain their market position and ensure patient safety.

Moreover, the rapid pace of technological advancements in the healthcare sector can also act as a restraining factor for the gastrointestinal cancer devices market. Manufacturers are under constant pressure to innovate and keep up with the latest technologies, which can lead to increased research and development costs. Smaller companies may struggle to compete with larger corporations that have more substantial resources and established market presence. Furthermore, fluctuations in healthcare spending due to economic uncertainties could affect the overall demand for gastrointestinal cancer devices. As healthcare budgets tighten, providers may be compelled to prioritize cost-effective solutions over advanced devices, impacting market dynamics. Companies need to navigate these challenges strategically to ensure sustained growth and innovation in the market.

Competitor Outlook

• Medtronic
• Boston Scientific Corporation
• Olympus Corporation
• Ethicon (Johnson & Johnson)
• Cook Medical
• Stryker Corporation
• Hologic, Inc.
• Siemens Healthineers
• Fujifilm Holdings Corporation
• Conmed Corporation
• Micro-Tech Endoscopy
• Varian Medical Systems
• Medline Industries, Inc.
• Bracco Imaging S.p.A.
• Endogastric Solutions, Inc.

The competitive landscape of the gastrointestinal cancer devices market is characterized by the presence of several prominent players, each striving to innovate and capture market share. Major companies such as Medtronic and Boston Scientific Corporation lead the market with their extensive portfolios of advanced medical devices tailored for gastrointestinal cancer care. Medtronic, a global leader in medical technology, continues to expand its product offerings in endoscopic and surgical devices, focusing on improving patient outcomes through innovative solutions. On the other hand, Boston Scientific is well-known for its state-of-the-art diagnostic and therapeutic devices, particularly in minimally invasive procedures for treating gastrointestinal cancers. The ongoing investments in research and development by these companies are crucial in maintaining their competitive advantage and responding to the evolving needs of healthcare professionals and patients.

Other notable competitors, such as Olympus Corporation and Ethicon (a Johnson & Johnson company), are also significant players in the market. Olympus Corporation specializes in endoscopic devices, providing comprehensive solutions that enhance the visualization and treatment of gastrointestinal conditions. Meanwhile, Ethicon is recognized for its surgical devices, offering a range of products designed for effective cancer surgery. Both companies are committed to advancing technology in gastrointestinal cancer devices, consistently introducing innovative products that meet the demands of the evolving healthcare landscape. As competition intensifies, these companies are likely to engage in strategic partnerships and collaborations to accelerate the development of new devices and expand their market reach.

In addition to these key players, companies like Cook Medical and Hologic, Inc. are making strides in the gastrointestinal cancer devices market. Cook Medical is known for its extensive range of therapeutic and diagnostic products, catering to various aspects of cancer treatment. The company’s focus on addressing unmet needs in gastrointestinal care through innovation positions it well for future growth opportunities. Hologic, Inc., primarily recognized for its diagnostic and imaging solutions, is expanding its product line to address the specific challenges presented by gastrointestinal cancers. As these companies continue to innovate and adapt to changing market dynamics, their contributions will play a crucial role in shaping the future of gastrointestinal cancer devices.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Conmed Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Olympus Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Stryker Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Micro-Tech Endoscopy
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Siemens Healthineers
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Bracco Imaging S.p.A.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Varian Medical Systems
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Medline Industries, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Endogastric Solutions, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ethicon (Johnson & Johnson)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Gastrointestinal Cancer Devices Market, By user
    • 6.1.1 Hospitals
    • 6.1.2 Specialty Clinics
    • 6.1.3 Cancer Research Institutes
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Others
  • 6.2 Gastrointestinal Cancer Devices Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Ambulatory Surgical Centers
    • 6.2.4 Cancer Research Institutes
    • 6.2.5 Others
  • 6.3 Gastrointestinal Cancer Devices Market, By Product Type
    • 6.3.1 Endoscopic Devices
    • 6.3.2 Surgical Devices
    • 6.3.3 Diagnostic Devices
    • 6.3.4 Therapeutic Devices
    • 6.3.5 Supportive Care Devices

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Gastrointestinal Cancer Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Gastrointestinal Cancer Devices market is categorized based on

By Product Type

• Endoscopic Devices
• Surgical Devices
• Diagnostic Devices
• Therapeutic Devices
• Supportive Care Devices

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Others

By user

• Hospitals
• Specialty Clinics
• Cancer Research Institutes
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific Corporation
• Olympus Corporation
• Ethicon (Johnson & Johnson)
• Cook Medical
• Stryker Corporation
• Hologic, Inc.
• Siemens Healthineers
• Fujifilm Holdings Corporation
• Conmed Corporation
• Micro-Tech Endoscopy
• Varian Medical Systems
• Medline Industries, Inc.
• Bracco Imaging S.p.A.
• Endogastric Solutions, Inc.